Clinical Trial Update: Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for a topical therapy in cutaneous mastocytosis reports terminated status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Mastocytosis

Drugs mentioned

• Topical Composition Therapy

Snippet

Sponsor: Joseph Butterfield | Conditions: Cutaneous Mastocytoses | Phase 2 | Status: TERMINATED | Results posted: 2024-04-25